Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-051266
Filing Date
2005-03-15
Accepted
2005-03-15 17:30:13
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1307390
2 FORM OF STOCK OPTION AGREEMENT dex1046.htm EX-10.46 16315
3 SECOND AMENDED AND RESTATED COLLABORATION, LICENSE AND SUPPLY AGREEMENT dex1049.htm EX-10.49 170812
4 FIRST SIDE AGREEMENT dex1050.htm EX-10.50 19959
5 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED AGREEMENT dex1051.htm EX-10.51 31093
6 LIST OF SUBSIDIARIES dex211.htm EX-21.1 2391
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2690
8 CERTIFICATION dex311.htm EX-31.1 9704
9 CERTIFICATION dex312.htm EX-31.2 9552
10 CERTIFICATION dex321.htm EX-32.1 3116
11 CERTIFICATION dex322.htm EX-32.2 3033
  Complete submission text file 0001193125-05-051266.txt   1578858
Mailing Address 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121
Business Address 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121 858 410 4600
NANOGEN INC (Filer) CIK: 0001030339 (see all company filings)

EIN.: 330489621 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23541 | Film No.: 05682744
SIC: 3826 Laboratory Analytical Instruments